Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Change in Accured Expenses (2020 - 2026)

RxSight filings provide 6 years of Change in Accured Expenses readings, the most recent being $1.7 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 51.26% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.9 million, a 131.95% decrease, with the full-year FY2025 number at -$1.9 million, down 131.95% from a year prior.
  • Change in Accured Expenses hit $1.7 million in Q4 2025 for RxSight, up from $1.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.7 million in Q3 2024 to a low of -$6.2 million in Q1 2025.
  • Median Change in Accured Expenses over the past 5 years was $1.5 million (2023), compared with a mean of $740200.0.
  • Biggest five-year swings in Change in Accured Expenses: soared 421.04% in 2021 and later plummeted 191.16% in 2022.
  • RxSight's Change in Accured Expenses stood at $1.6 million in 2021, then skyrocketed by 51.44% to $2.4 million in 2022, then decreased by 9.52% to $2.2 million in 2023, then surged by 58.72% to $3.5 million in 2024, then crashed by 51.26% to $1.7 million in 2025.
  • The last three reported values for Change in Accured Expenses were $1.7 million (Q4 2025), $1.6 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.